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Severe anaemia is a major cause of paediatric hospital admissions 
and deaths in many African countries, with a hospital prevalence of 
10 - 30% and case fatality rates between 4 and 10%.1,2 Anaemia, in 
which blood oxygen carrying capacity is reduced, is characterised by 
a low haemoglobin concentration.3 The World Health Organization 
(WHO) defined severe anaemia in patients with malaria as a 
haemoglobin concentration less than 50 g/l.3Anaemia becomes life-
threatening when affected individuals develop complications such 
as heart failure, metabolic acidosis and hypoxic encephalopathy.4
Severe falciparum malaria remains the leading cause of 
paediatric anaemia in sub-Saharan Africa.1,2,4 Anaemia may 
develop in children already debilitated by other conditions such 
as nutritional deficiencies, bacteraemia, human immunodeficiency 
viral (HIV) infections, haemoglobinopathy, glucose-6-phosphate 
dehydrogenase (G6PD) deficiency, hookworm infestation and 
leukaemia. In most cases, these factors tend to co-exist.1
Severe anaemia-related deaths continue to occur in many centres 
in the tropics, even where blood transfusion services are readily 
available.1,2 To limit this mortality, we studied children admitted 
with severe anaemia in a newly established tertiary health centre 
requirements for POC positioning of Xpert exceeded expectations. 
As a result, the responsibilities transferred from laboratory to clinic 
went beyond sample processing. The magnitude of the challenges 
will be highly dependent on the existing infrastructure and current 
organisation of TB diagnosis and treatment facilities. Programmes will 
therefore need to carefully weigh the benefits against infrastructural 
and human resource needs when deciding on a POC or laboratory 
policy for implementation of Xpert MTB/RIF. 
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Determinants of mortality in Nigerian children 
with severe anaemia
Samuel Adegoke, Adenike Ayansanwo, Isaac Oluwayemi, John Okeniyi
Background. Severe anaemia (haemoglobin concentration <50 g/l) is a 
major cause of paediatric hospital admissions and deaths in the tropics.
Objectives.To examine the pattern and predictors of mortality 
among severely anaemic children.
Methods. A prospective cross-sectional study was conducted 
among children with severe anaemia at the Children’s Emergency 
Room of the University Teaching Hospital, Ado-Ekiti, Nigeria. Socio-
demographic characteristics, clinical features, laboratory findings and 
co-morbidities of the survivors and those who died were compared by 
logistic regression analysis.
Results. Of the 1 735 children admitted, 311 (17.9%) had severe 
anaemia, with a case-fatality rate of 9.3%. The presence of respiratory 
distress (95% confidence interval (CI) 2.1 - 3.6, p=0.031); acidosis 
(95% CI 1.8 - 2.7, p=0.010); coma (95% CI 0.1 - 0.3, p=0.001); 
hypotension (95% CI 2.0 - 4.2, p=0.020); and bacteraemia (95% CI 3.1 
- 3.9; p=0.008) were the significant independent predictors of death 
with regression analysis.
Conclusion. Early recognition with prompt and appropriate 
anticipatory intervention is essential to reduce mortality from severe 
anaemia.
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in south-western Nigeria to determine the mortality rate and its 
predictive factors. Identifying these factors may facilitate prompt 
use of adjunct therapies including blood transfusion in high-risk 
children.
Methods
This was a prospective cross-sectional study of consecutive children 
admitted with severe anaemia at the Children’s Emergency Room 
(CHER) of the University Teaching Hospital, Ado-Ekiti, Ekiti 
state, Nigeria, from January to December 2010. The hospital was 
established about 50 years ago as a secondary health institution, and 
was upgraded about three years ago to a tertiary health institution to 
serve the growing health needs of a sizeable part of south-western 
Nigeria.
Severely anaemic children were those with venous haematocrit of 
<15% (haemoglobin concentration <50 g/l).3 All patients required 
emergency blood transfusion. Informed parental consent was 
obtained in all cases. Permission for the study was granted by the 
Ethics and Research Committee of the hospital.
Biodata (age, gender and socio-economic status) and other 
information, e.g. presenting symptoms (fever, pallor, jaundice and passage 
of dark-brown urine and their respective duration) and relevant clinical 
examination findings, were recorded. The socio-economic status was 
based on the highest parental level of education and occupation.5
Duration of illness was the interval between its onset and 
presentation in our unit and was considered prolonged when over 72 
hours. Adequacy of antimalarial treatment before presentation was 
taken as WHO Artemisinin Combination Therapy (ACT) for the 
appropriate duration.
Nutritional status was assessed using the National Center for 
Health Statistics and WHO (NCHS/WHO) definition of wasting, 
underweight and stunting.6 Those with weight-for-height below 2 
standard deviations (SD) were categorised as wasted, weight-for-
age below 2 SD as underweight, and height/length-for-age below 
2 SD as stunted. The level of consciousness was assessed using the 
Blantyre Coma Scale (a modification of the Glasgow Coma Scale). 
Blood pressure (BP) was measured with the age-appropriate Accuson 
mercurial sphygmomanometer by standard techniques. Using the 
Paediatric Task Force guidelines on BP control, children with systolic 
and/or diastolic BP below the 5th percentile for age, gender and 
height were categorised as hypotensive.7
Oxygen saturations (SaO2) were measured using a pulse oximeter 
(Nell core, N-200, USA) with an appropriately sized paediatric probe 
attached to the finger or toenail bed. The reading of the oximeter was 
recorded after stabilisation of the reading for 1 minute by a paediatric 
nurse not involved in the clinical examination. Hypoxaemia was 
defined as SaO2<90%.8
Venous blood samples were taken on admission for the haematocrit 
concentration, white blood cell count (total and differential count), 
platelet count, thick and thin blood film for malaria parasites, 
serum glucose, bicarbonate and creatinine estimations, blood 
culture, haemoglobin electrophoresis and glucose-6-phosphate 
dehydrogenase (G6PD) assay. Haematocrit levels and complete blood 
counts were determined by standard manual methods.9 Malaria was 
defined as the presence of Plasmodium falciparum asexual parasites 
in the blood. All the patients had standard bacterial cultures and 
sensitivity tests.9
The survivors and the dead were compared in terms of 
sociodemographic characteristics (age, gender, socio-economic 
status), clinical symptoms and signs including duration of illness 
before presentation and adequacy of therapy before presentation. 
Laboratory findings, e.g. haematocrit and complete blood count, 
and the presence of co-morbidities such as acidosis (serum 
bicarbonate <20 mmol/l), hypoglycaemia (serum glucose <2.2 
mmol/l), bacteraemia, haemoglobinopathy and HIV infection, were 
also compared.
The data were analysed using SPSS version 17. Tests of association 
between the variables and the outcome were performed with chi-
squared and Student’s t-tests for categorical and continuous variables 
respectively. Variables associated with statistically significant 
mortality were further analysed with logistic regression modelling to 
identify the independent predictive factors of mortality in children 
with severe anaemia. Results of logistic regression were presented 
with odds ratios (ORs) and 95% confidence intervals (CIs). Statistical 
significance was established when p-values were <0.05 and the CI 
excluded unity.
Results
During the study, 1 735 children were admitted; 311 had severe 
anaemia, a prevalence of 17.9%; 199 (64.0%) were males (male-to-
female ratio 1.8:1). Ages ranged from 2 to 161 months with the mean 
age 30.9 (SD 16.7) months. Of the 311 children, 56 (18.0%) were infants 
under 1 year of age, 218 (70.1%) were preschool children (>1 - 5 years), 
29 (9.3%) were school-age (>5 - 10 years), 8 (2.6%) were adolescents 
(>10 years), 260 (83.6%) were of low socio-economic status (III - V) 
and 51 (16.4%) were of high socio-economic status (I and II).
Malaria, the leading cause of severe anaemia, occurred in 282 
(90.7%), either alone or in combination with other diseases: 81 
(26.0%) had bacteraemia, 40 (12.9%) had sickle-cell anaemia and 
were in haemolytic crisis, 20 (6.4%) had significant bleeding from 
injuries, 16 (5.1%) were G6PD-deficient and 3 (1.0%) had chronic 
kidney disease.
Of the 311 children with severe anaemia, 29 died during the study 
period (case-fatality rate 9.3%), representing 33.0% of the 88 deaths 
in CHER during the period. The remaining 282 (90.7%) survived and 
were discharged. Of the 29 children who died, 8 (24.1%) died before 
blood transfusion was given.
The mean age of the survivors was 36.2 (SD 30.5) months (range 2 - 
161 months). The ages of those who died ranged from 2 to 72 months 
with a mean of 18.8 (SD 8.1) months. Children with severe anaemia 
who died were significantly younger than survivors (t=2.44, p=0.014).
Among survivors, the duration of illness before presentation 
ranged from 1 to 13 days with a mean of 4.5 (SD 2.5) days; among 
those who died, illness duration ranged from 2 to 21 days, with a 
mean of 6.7 (SD 6.0) days. The average duration of illness before 
presentation was significantly longer among the severely anaemic 
children who died than among the survivors (t=3.07, p=0.002).
The mean interval between presentation and blood transfusion for 
those who survived was 3.1 (SD 3.6) hours and 2.5 (SD 3.8) hours 
for those who died. However, there was no statistically significant 
difference in the interval between presentation and transfusion 
among the two groups of children (t=0.69, p=0.492).
Table I compares the sociodemographic characteristics, and the 
clinical and laboratory findings, at presentation of the survivors 
and those who died. Respiratory distress, tachypnoea, heart failure, 
hypotension, coma and severe wasting were significantly related to 
poor outcome (p<0.005).
The haematocrit ranged from 6% to 19% among survivors and 
from 6% to 17% among those who died, with an overall mean 
of 12.9% (SD 1.1%). The mean haematocrit of those who died 
was 11.7% (SD 2.6%) and did not differ significantly from that of 
survivors (13.9% (SD 3.8%) (t=0.18, p=0.855)).
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Of the 282 children with malaria, 123 (43.6%) had high-density 
parasitaemia (>10 000/µl), including 109 (38.7%) of the 282 survivors 
and 14 (48.3%) of the 29 who died. Although a higher proportion of 
those who died had high-density parasitaemia, the difference was not 
statistically significant (χ2=1.019, p=0.313). Similarly, the proportion 
of children with leucopenia or thrombocytopenia who died did not 
significantly differ from those who survived (p=0.152 and 0.217 
respectively).
Of the 27 children with elevated serum creatinine levels (>110 
µmol/l), 19 (70.4%) died (p=0.001). The mean serum creatinine level 
of the children who died was 119.6 µmol/l (SD 23.1) – significantly 
higher than that of survivors at 92.5 µmol/l (SD 19.7) (p<0.001). The 
presence of acidosis, hypoglycaemia, hypoxaemia, bacteraemia and 
cerebral malaria was significantly related to death (p<0.05) (Table 1).
Predictive factors for mortality among children with severe 
anaemia were analysed by binary logistic regression of all the 
variables initially found to be significantly related to death using 
Pearsons’s chi-squared test of association. Table 2 shows that the 
presence of respiratory distress (95% CI 2.1 - 3.6, p=0.031), acidosis 
(95% CI 1.8 - 2.7, p=0.010), coma (95% CI 0.1 - 0.3, p=0.001), 
hypotension (95% CI 2.0 - 4.2, p=0.020) and bacteraemia (95% CI 
3.1 - 3.9, p=0.008) were significant independent predictors of death 
in children with severe anaemia.







Infants 45 (16.0) 11 (37.9) 0.003
Male gender 178 (63.1) 21 (72.4) 0.321
Low socio-economic status 235 (83.3) 24 (82.8) 0.937
Prolonged duration of illness 48 (17.0) 14 (48.3) <0.001
Inadequate prehospital treatment 124 (44.0) 9 (31.0) 0.180
Fever 274 (97.2) 29 (100.0) 0.762
Respiratory distress† 197 (69.9) 28 (96.6) 0.004
Jaundice 99 (35.1) 9 (31.0) 0.661
Convulsion 105 (37.2) 15 (51.7) 0.127
Coma 107 (37.9) 20 (69.0) 0.001
Tachycardia 199 (70.6) 25 (86.2) 0.117
Hypotension 25 (8.9) 9 (31.0) <0.001
Heart failure 165 (58.5) 26 (89.7) 0.002
Underweight 117 (41.5) 14 (48.3) 0.481
Wasting 33 (11.7) 11 (37.9) <0.001
Acidosis 100 (35.5) 18 (62.1) 0.005
Hypoglycaemia 45 (16.0) 10 (34.5) 0.013
Hypoxaemia (SaO2<90%) 18 (6.4) 7 (24.1) 0.001
Bacteraemia 65 (23.0) 16 (55.2) <0.001
Cerebral malaria 88 (31.2) 19 (65.5) <0.001
Sickle-cell anaemia 36 (12.8) 4 (13.8) 1.000
G6PD deficiency 13 (4.6) 3 (10.3) 0.374
HIV 17 (6.0) 3 (10.3) 0.614
*P-values in bold font denote significance.
†Respiratory distress refers to presence of fast breathing, chest in-drawing, grunting or flaring of nostrils.
Table 2. Predictive factors for mortality among children with 
severe anaemia by binary logistic regression analysis
Variables OR 95% CI p-value*
Infancy 0.33 0.2 - 2.6 0.566
Prolonged duration of illness 0.23 0.2 - 2.5 0.934
Respiratory distress 0.13 2.1 - 3.6 0.031
Tachypnoea 0.21 1.3 - 2.1 0.412
Heart failure 0.17 0.4 - 1.1 0.064
Wasting 0.23 0.3 - 0.8 0.108
Hypotension 0.22 2.0 - 4.2 0.020
Coma 0.28 0.1 - 0.3 0.001
Hypoxaemia 0.19 0.8 - 2.2 0.212
Acidosis 0.32 1.8 - 2.7 0.010
Hypoglycaemia 0.33 0.2 - 1.4 0.169
Cerebral malaria 0.18 1.4 - 4.3 0.072
Bacteraemia 0.22 3.1 - 3.9 0.008
Serum creatinine level 0.01 0.6 - 7.3 0.273
*P-values in bold font denote significance.
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Discussion
Childhood anaemia remains a serious health problem in most of sub-
Saharan Africa.10 In this study, severe anaemia accounted for 17.9% 
of paediatric emergencies, which is within the 10 - 30% hospital 
prevalence in some African studies.1,2 However, in areas where 
delayed presentation to the hospital is common, hospital incidence of 
severe anaemia was higher.11 In this study, severe anaemia was more 
prevalent among preschool children and infant males from the low 
socio-economic status. This is probably because the same group of 
children are more susceptible to malaria, which accounted for more 
than 90% of cases of severe anaemia in our unit, either singly or in 
combination with other diseases.
Our in-hospital case fatality rate of 9.3% is also similar to those 
in previous studies.1,2 Mortality remains high, despite availability of 
blood transfusion services in our hospital. Sadly, one out of every 
four severely anaemic children died before blood transfusion was 
given.
In this study, severely anaemic children who died were significantly 
younger than survivors (mean age 18.8 (SD 8.1) v. 36.2 (SD 30.5) 
months). Younger children, particularly infants and preschool 
children, tend to develop severe anaemia more rapidly during 
haemolytic processes because of their low iron stores and poor 
immune response to P. falciparum infection.12
Prolonged duration of illness (>72 hours) before presentation was 
significantly related to poor outcome among our patients. Although 
it was not found to be an independent predictor of death with 
regression analysis, longer duration of illness or repeated attacks 
of untreated illness before presentation are likely determinants of 
anaemia severity.
Our finding of respiratory distress as a predictor of adverse 
outcome among children with severe anaemia agrees with previous 
studies.1,13 Respiratory distress (presence of fast breathing, chest 
in-drawing, grunting and flaring of nostrils) increases case fatality 
rates of severely anaemic children 10 times.13 This may result from 
lower oxygen concentration and metabolic acidosis commonly 
seen in such children. In this study, hypoxaemia (SaO2<90%) and 
metabolic acidosis were also significantly related to death. Features 
such as tachypnoea, tachycardia, hepatomegaly, gallop rhythm, 
lethargy and grunting, which are characteristic of heart failure in 
anaemic children, are thought to arise from lactic acidosis.4,13
Consistent with previous studies,12,13 high-density parasitaemia 
was neither significantly related nor a predictor of death from severe 
anaemia. A study on the clinical predictors of severe malaria anaemia 
in a holo-endemic P. falciparum transmission area found that children 
with uncomplicated malaria had more peripheral parasitaemia, geo-
mean parasitaemia and proportion of high-density parasitaemia 
than those with severe anaemia.13 Our findings therefore support the 
hypothesis that immune response to P. falciparum rather than the 
cumulative parasite burden may be the primary factor responsible 
for the development and promotion of severe malaria anaemia in 
holo-endemic regions.13
Of our patients, 26% had bacteraemia and 55.2% of those who died 
had bacteraemia. Hence, in Africa, where bacterial infections such as 
staphylococcal and Salmonella infections are prevalent,14 the use of 
antibiotics for severely anaemic children may be justified, especially 
where blood culture facilities are not readily available. Our study 
found that hypotension predicted death among the children with 
severe anaemia, consistent with Maitland et al.14 who concluded that, 
although hypovolaemia and resultant hypotension are infrequently 
seen in children with severe malaria, impaired tissue perfusion shares 
features with sepsis syndrome and significantly contributed to deaths.
Children with severe anaemia may present with coma owing 
to metabolic dysfunction (lactic acidosis and/or hypoxia) which 
depresses the level of consciousness.15 In our study, more patients with 
coma died, which indicates that aggressive resuscitation measures are 
needed for children with coma and severe anaemia.
Our study shows that mortality risk in children with severe anaemia 
depends on clinical characteristics such as respiratory distress, coma, 
hypotension and presence of co-morbidities, especially acidosis and 
bacteraemia. In Africa, where severe anaemia is prevalent and causes 
considerable childhood morbidity and mortality, early identification 
of these factors, anticipatory supportive care and timely resuscitative 
measures in addition to blood transfusion are essential to reducing 
deaths from severe anaemia.
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